Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real‐life clinical practice) study
出版年份 2021 全文链接
标题
Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the
CANOVA
(
EffeCtiveness
of biologic
treAtmeNts
for plaque
psOriasis
in Italy: An
obserVAtional
longitudinal study of real‐life clinical practice) study
作者
关键词
-
出版物
Dermatologic Therapy
Volume 35, Issue 1, Pages -
出版商
Wiley
发表日期
2021-10-22
DOI
10.1111/dth.15166
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug Survival of Adalimumab, Ustekinumab, and Secukinumab in Patients with Psoriasis: a Prospective Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
- (2020) Z.Z.N. Yiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Real‐world evidence of secukinumab in psoriasis treatment – a meta‐analysis of 43 studies
- (2020) M. Augustin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2‐year period
- (2020) M. Megna et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL)
- (2020) J. Seneschal et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real‐world evidence study
- (2020) J.F.B. Schwensen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab Drug Survival in Patients with Psoriasis: A multicenter, real-world, retrospective study
- (2019) Tiago Torres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
- (2019) Matteo Megna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study
- (2019) Natalia Rompoti et al. Dermatologic Therapy
- Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
- (2019) Andrea Chiricozzi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Comparison of Real-World Treatment Patterns among Psoriasis Patients Prescribed Ixekizumab or Secukinumab
- (2019) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
- (2019) Marco Galluzzo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
- (2018) Aleksandra G. Florek et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naïve patients from the French national health insurance database (SNIIRAM)
- (2018) E. Sbidian et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity
- (2018) Mwangi J. Murage et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis
- (2018) Jawad Bilal et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
- (2018) Farzad Alinaghi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review
- (2018) Francesca Prignano et al. Current Rheumatology Reports
- Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
- (2018) Pei-Tzu Lin et al. Scientific Reports
- Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
- (2018) L.M. Sawyer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis
- (2017) Jillian Frieder et al. Expert Review of Clinical Immunology
- Epigenetics of psoriatic disease: A systematic review and critical appraisal
- (2017) Remy A. Pollock et al. JOURNAL OF AUTOIMMUNITY
- PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis
- (2017) Carlo Giovanni Carrera et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Drug survival of biologic treatments in psoriasis: a systematic review
- (2017) Daniel J. No et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis
- (2017) Zarif K. Jabbar-Lopez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Real-world burden of comorbidities in US patients with psoriasis
- (2017) Kamal Shah et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis and comorbid diseases
- (2017) Junko Takeshita et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
- (2017) A. Körber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
- (2016) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A systematic review of worldwide epidemiology of psoriasis
- (2016) I.M. Michalek et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment Satisfaction of Patients with Psoriasis
- (2015) M Schaarschmidt et al. ACTA DERMATO-VENEREOLOGICA
- Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
- (2015) Axel Patrice Villani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
- (2012) Rosa Parisi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Definition of treatment goals for moderate to severe psoriasis: a European consensus
- (2010) U. Mrowietz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
- (2008) M.K.A. Basra et al. BRITISH JOURNAL OF DERMATOLOGY
- Regional distribution of psoriasis in Italy
- (2007) R Saraceno et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started